1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe SIRA/CHA pilot grant program solicits proposals for innovative research projects or novel analyses of data with aging as a focus. The purpose of the pilot funding is to foster early-stage research focused on the study and promotion of healthy aging.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: All UC San Diego faculty members and postdoctoral fellows. Projects should be related to understanding factors that impact healthy aging or advancing innovative strategies for promoting healthy aging. Confirm the full requirements in the official notice before applying.
The current listing shows $20,000-$40,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
SIRA/CHA Pilot Grant Program is funded by Stein Institute for Research on Aging and the UC San Diego Center for Healthy Aging. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
On August 14, 2026, the California Arts Council approved nearly $24.6 million across 1,200 grant awards. Buried in the release is a rare thing: before-and-after data showing exactly how much the ranked-priority bonus moved the pool. Small organizations went from 53% of applicants to 72% of awardees. Geography moved 19 points. First-time status barely moved at all. Here is what that means for the 2027 cycle.
Read articleSeven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read article